Andere talen Spruce Biosciences, Inc.

Aandelen

SPRB

US85209E1091

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 01-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,7174 ^USD	+1,33%		+2,22%	-75,52%

14/03	Top Middag Decliners	MT
14/03	Sectorupdate: Gezondheidszorgaandelen donderdagmiddag lager	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Spruce Biosciences : Failure to Satisfy Listing Rule - Form 8-K	11:10
Spruce Biosciences to Participate in May Investor Conferences	01/05
Spruce Biosciences Announces Additional Poster Presentation at the Pediatric Endocrine Society 2024 Annual Meeting	30/04
Spruce Biosciences Announces Upcoming Poster Presentation at the Pediatric Endocrine Society 2024 Annual Meeting	22/04
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Spruce Biosciences, Inc. - SPRB	05/04
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Spruce Biosciences, Inc. - SPRB	27/03
Spruce Biosciences, Inc. (SPRB) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings	21/03
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Spruce Biosciences, Inc. - SPRB	19/03
North American Morning Briefing : Inflation -2-	15/03
Spruce Biosciences, Inc. (SPRB) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings	14/03
Top Midday Decliners	14/03
Sector Update: Health Care Stocks Lower Thursday Afternoon	14/03
Sector Update: Health Care Stocks Mixed Pre-Bell Thursday	14/03
Spruce Biosciences 2023 Loss Narrows; to Cut 21% Workforce After Trial Misses Target; Shares Sink	13/03
Spruce Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	13/03
Spruce Biosciences Reports Full Year 2023 Financial Results and Provides Corporate Updates	13/03
Spruce Biosciences Announces Topline Results from CAHmelia-203 in Adult Classic CAH and CAHptain-205 in Pediatric Classic CAH	13/03
Spruce Biosciences, Inc. Announces Topline Results from CAHmelia-203 in Adult Classic CAH and CAHptain-205 in Pediatric Classic CAH	13/03
Top Premarket Decliners	13/02
Spruce Biosciences to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference	30/01

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Spruce Biosciences, Inc.

Aandelen

SPRB

US85209E1091

Andere talen

Filters